Suppr超能文献

白塞病的草药疗法:一项系统评价与荟萃分析方案

Herbal medicine for Behcet's disease: A protocol for a systematic review and meta-analysis.

作者信息

Jun Ji Hee, Choi Tae-Young, Zhang Junhua, Ko Mi Mi, Lee Myeong Soo

机构信息

Clinical Research Division, Korea Institute of Oriental Medicine Department of Preventive Medicine, College of Korean Medicine, Daejeon University, Daejeon, Republic of Korea Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China Department of Korean Medicine Life Science, Korea University of Science & Technology, Daejeon, Republic of Korea.

出版信息

Medicine (Baltimore). 2018 Mar;97(13):e0165. doi: 10.1097/MD.0000000000010165.

Abstract

BACKGROUND

Herbal medicine treatment is often recommended in order to raise immunity levels and reduce the possibility of recurrence of symptoms, and treating the fundamental causes of the disease. This systematic review will assess the efficacy of herbal medicine in treating Behcet's disease.

METHODS AND ANALYSIS

We will search the following 11 electronic databases from their inception: PubMed, EMBASE, and CENTRAL; 3 Chinese databases (CNKI, Wanfang, and VIP); and 5 Korean databases (OASIS, DBpia, RISS, KISS, and KoreaMed). The data will be extracted independently by 2 authors using predefined criteria. Disagreements will be resolved by discussion between the authors. The risk of bias will be assessed using the Cochrane tool for assessing risk of bias.

ETHICS AND DISSEMINATION

Ethical approval will not be required, given that this protocol is for a systematic review. The review will be published in a journal. Updates of the review will be conducted periodically to inform and guide healthcare practice and policy.

TRIAL REGISTRATION NUMBER

PROSPERO 2018 CRD42018085493.

摘要

背景

草药疗法常被推荐用于提高免疫力、降低症状复发可能性以及治疗疾病的根本病因。本系统评价将评估草药治疗白塞病的疗效。

方法与分析

我们将检索以下11个电子数据库自建库以来的数据:PubMed、EMBASE和CENTRAL;3个中文数据库(中国知网、万方和维普);以及5个韩国数据库(OASIS、DBpia、RISS、KISS和KoreaMed)。数据将由2名作者根据预定义标准独立提取。分歧将通过作者间讨论解决。将使用Cochrane偏倚风险评估工具评估偏倚风险。

伦理与传播

鉴于本方案为系统评价,无需伦理批准。本评价将发表在某期刊上。将定期对评价进行更新,为医疗实践和政策提供信息与指导。

试验注册号

PROSPERO 2018 CRD42018085493。

相似文献

本文引用的文献

2
Behcet's disease.白塞病
Clin Exp Med. 2004 Sep;4(1):10-20. doi: 10.1007/s10238-004-0033-4.
5
Treatment of Behçet's disease--an update.白塞病的治疗——最新进展
Semin Arthritis Rheum. 2001 Apr;30(5):299-312. doi: 10.1053/sarh.2001.19819.
6
Complementary medicine use by patients with inflammatory bowel disease.炎症性肠病患者使用补充医学的情况。
Am J Gastroenterol. 1998 May;93(5):697-701. doi: 10.1111/j.1572-0241.1998.208_a.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验